Oppenheimer lowered the firm’s price target on Varex Imaging (VREX) to $18 from $23 and keeps an Outperform rating on the shares. The firm notes Varex’s Q4 revenues of $229M came in ahead of its/consensus $221M/$219M estimates and on the high end of the $210M-$230M guide. Varex also reported Q1 2026 revenue guidance of $200M-$215M, bracketing Oppenheimer/consensus $207/$206M estimates.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VREX: